{
  "id": 26081,
  "title": "AtaiBeckley attracted co-development and royalty offers before $2.8B Lilly deal",
  "url": "https://urgent.news/2026/07/30/ataibeckley-attracted-co-development-and-royalty-offers-before-2-8b",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-07-30T15:10:46.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/ataibeckley-attracted-co-development-and-royalty-offers-before-2-8b-lilly-deal/"
  },
  "original_language": "en",
  "account": null,
  "summary": "More details have emerged about how the industry’s largest psychedelic biotech buyout came to fruition. In an SEC filing on Thursday morning, AtaiBeckley disclosed some of the play-by-play from its",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}